2-amino-2-tricyclo<3.3.1.1^3,7>decanemethanol | 55213-85-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-amino-2-tricyclo<3.3.1.1^3,7>decanemethanol
• 英文别名: ((1r,3r,5r,7r)‐2‐aminoadamantan‐2‐yl)methanol；Amino-2-hydroxymethyl-2-adamantan；2-Amino-2-hydroxymethyl-adamantan；2-amino-2-adamantanemethanol；(2-amino-adamantan-2-yl)-methanol；(2-Aminoadamantan-2-yl)methanol；(2-amino-2-adamantyl)methanol
• CAS: 55213-85-9
• 化学式: C₁₁H₁₉NO
• 分子量: 181.278
• InChiKey: JNAKWHJSIJOZFK-UHFFFAOYSA-N

物化性质

• 熔点：
  214 °C
• 沸点：
  292.8±13.0 °C(Predicted)
• 密度：
  1.105±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  46.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-amino-2-tricyclo<3.3.1.1^3,7>decanemethanol 在 氢氧化钾 、 lithium aluminium tetrahydride 、 三乙胺 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 乙醚 、 二氯甲烷 为溶剂， 反应 54.0h， 生成 4-(ethoxycarbonyl)spiro[morpholine-3,2'-tricyclo[3.3.1.1^3,7]decane]
  参考文献：
  名称：

  Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. 2

  摘要：

  The synthesis of some new aminoadamantane derivatives is described. The new compounds were evaluated against a wide range of viruses [influenza A H1N1, influenza A H2N2, influenza A H3N2, influenza B, parainfluenza 3, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), thymidine kinase-deficient (TK-) HSV-1, vaccinia, vesicular stomatitis, polio 1, Coxsackie B4, Sindbis, Semliki forest, Reo 1, varicella-zoster virus (VZV), TK- VZV, human cytomegalo-virus (HCMV),,and human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2)]. Some of them proved markedly active against the influenza A H2N2 (compounds 4a,b, 5a, 6a, and 7a), H3N2 (compounds 5a, 6a, and 7a), and H1N1 (compounds 4b,c and 6d). Since compounds 5a, 6a, and 7a, amantadine, and rimantadine showed the same comparative pattern of potency against influenza strains H2N2, H3N2, and B, it may postulated that they act according to a similar mechanism, with regard to their ''amine'' effect, on the M2 ion channel of influenza A (H1N1, H2N2, or H3N2). In general, no significant activity was noted with any of the new compounds against any of the other viruses tested, making their activity against influenza virus more specific and striking. Borderline activity was noted with some of the compounds (4b,c, 5a-c, and 8a) against HIV-1.

  DOI：

  10.1021/jm950891z
• 作为产物：
  描述：

  2-nitro-2-adamantanemethanol 在 氢气 作用下， 以 乙醇 为溶剂， 50.0 ℃ 、379.22 kPa 条件下， 以99%的产率得到2-amino-2-tricyclo<3.3.1.1^3,7>decanemethanol
  参考文献：
  名称：

  Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines

  摘要：

  Adamantanamines 16, 18, 21, 24, 27, 28, 30, 32, 35, 36, 37, 40, 46 and 48 were synthesized and tested for anti-influenza A virus and trypanocidal activity. The stereoelectronic requirements for optimal antiviral and trypanocidal potency were investigated. The effect of introducing a hydroxyl group close to the amino group on this class of compounds was examined for the first time. Aminoalcohol 24 proved to be the most active of the compounds tested against influenza A virus, being 6-fold more active than amantadine, equipotent to rimantadine and 26-fold more potent than ribavirin. Aminoalcohols 36 and 37 were found to have considerable activity against bloodstream forms of the African trypanosome, Trypanosoma brucei, being almost 10 times more potent than rimantadine. (C) 2010 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2010.08.009

文献信息

• Syntheses d'oxazolidines substituees par l'adamantane et de nitroxydes oxazolidines stables derives de l'adamantane
  作者：Claude Morat、André Rassat

  DOI：10.1016/s0040-4039(01)86649-1

  日期：1979.1

  Adamantane oxazolidine derivatives have been prepared. The corresponding mono and biradicals have molecular shapes well suited to the study of the motion anisotropy in solution.

  已经制备了金刚烷恶唑烷衍生物。相应的单自由基和双自由基具有非常适合研究溶液中运动各向异性的分子形状。
• Conformationally Constrained Adamantaneoxazolines of Pharmacological Interest
  作者：Andrew Tsotinis、Ioannis Papanastasiou、George B. Foscolos、Judit Ol�、Judit Ov�i、S. Radhika Prathalingam、John M. Kelly

  DOI：10.3987/com-08-11377

  日期：——
• MORAT C.; RASSAT A., TETRAHEDRON LETT., 1979, NO 47, 4561-4564
  作者：MORAT C.、 RASSAT A.

  DOI：——

  日期：——
• Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines
  作者：Grigoris Zoidis、Nicolas Kolocouris、John M. Kelly、S. Radhika Prathalingam、Lieve Naesens、Erik De Clercq

  DOI：10.1016/j.ejmech.2010.08.009

  日期：2010.11

  Adamantanamines 16, 18, 21, 24, 27, 28, 30, 32, 35, 36, 37, 40, 46 and 48 were synthesized and tested for anti-influenza A virus and trypanocidal activity. The stereoelectronic requirements for optimal antiviral and trypanocidal potency were investigated. The effect of introducing a hydroxyl group close to the amino group on this class of compounds was examined for the first time. Aminoalcohol 24 proved to be the most active of the compounds tested against influenza A virus, being 6-fold more active than amantadine, equipotent to rimantadine and 26-fold more potent than ribavirin. Aminoalcohols 36 and 37 were found to have considerable activity against bloodstream forms of the African trypanosome, Trypanosoma brucei, being almost 10 times more potent than rimantadine. (C) 2010 Elsevier Masson SAS. All rights reserved.
• Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. 2
  作者：Nicolas Kolocouris、Antonios Kolocouris、George B. Foscolos、George Fytas、Johan Neyts、Elisabeth Padalko、Jan Balzarini、Robert Snoeck、Graciela Andrei、Erik De Clercq

  DOI：10.1021/jm950891z

  日期：1996.1.1

  The synthesis of some new aminoadamantane derivatives is described. The new compounds were evaluated against a wide range of viruses [influenza A H1N1, influenza A H2N2, influenza A H3N2, influenza B, parainfluenza 3, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), thymidine kinase-deficient (TK-) HSV-1, vaccinia, vesicular stomatitis, polio 1, Coxsackie B4, Sindbis, Semliki forest, Reo 1, varicella-zoster virus (VZV), TK- VZV, human cytomegalo-virus (HCMV),,and human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2)]. Some of them proved markedly active against the influenza A H2N2 (compounds 4a,b, 5a, 6a, and 7a), H3N2 (compounds 5a, 6a, and 7a), and H1N1 (compounds 4b,c and 6d). Since compounds 5a, 6a, and 7a, amantadine, and rimantadine showed the same comparative pattern of potency against influenza strains H2N2, H3N2, and B, it may postulated that they act according to a similar mechanism, with regard to their ''amine'' effect, on the M2 ion channel of influenza A (H1N1, H2N2, or H3N2). In general, no significant activity was noted with any of the new compounds against any of the other viruses tested, making their activity against influenza virus more specific and striking. Borderline activity was noted with some of the compounds (4b,c, 5a-c, and 8a) against HIV-1.